Activation of NF-κB pathway in tumor cells has been implicated in the pathogenesis and resistance to chemotherapy, and suppression of NF-κB has been accepted as an attractive therapeutic approach for inhibiting glioma tumor cell proliferation and survival 4. Here, NFKB1 is linked to glioma.